As of 10:07:29 AM EST. Market Open. Evolus (EOLS) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock ...

I previously rated Evolus, Inc. stock a “Buy” due to its litigation settlement with AbbVie, strong revenue targets, and promising product performance. Despite positive updates, Evolus stock ...

The preliminary results for the fourth quarter and full-year 2024 underscore the strength of our operational execution and significant market ...

Leerink Partners analyst Marc Goodman has maintained their bullish stance on EOLS stock, giving a Buy rating yesterday.Invest with Confidence: ...